Nippon Chemiphar Co., Ltd.

4539

JP3701600003

Pharmaceuticals

Market Closed - Japan Exchange Other stock markets 07:00:00 17/05/2024 BST			5-day change	1st Jan Change
1,566 ^JPY	-0.25%		-2.97%	+0.32%

2023	Delta-Fly Pharma, Inc. announced that it has received ¥503.7238 million in funding from Nippon Chemiphar Co., Ltd.	CI
2023	Global EV battery supply chain puzzles over China graphite curbs	RE

Nippon Chemiphar Co., Ltd.(TSE:4539) dropped from S&P Global BMI Index

September 18, 2017 at 05:00 am

Latest news about Nippon Chemiphar Co., Ltd.

Delta-Fly Pharma, Inc. announced that it has received ¥503.7238 million in funding from Nippon Chemiphar Co., Ltd.	11-09	CI
Global EV battery supply chain puzzles over China graphite curbs	27/10/23	RE
Delta-Fly Pharma, Inc. announced that it expects to receive ¥503.7238 million in funding from Nippon Chemiphar Co., Ltd.	19/10/23	CI
InnoJin Co., Ltd announced that it has received Â¥220 million in funding from Sumitomo Corporation, Nippon Chemiphar Co., Ltd., SEED Co.,Ltd., JINS HOLDINGS Inc.	03/07/23	CI
Nippon Chemiphar Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023	12/05/23	CI
Activist fund targets maker of Maruchan ramen noodles over governance, sources say	16/05/22	RE
Japan's Hitachi to sell about 50% of its stake in construction unit	14/01/22	RE
MOLCURE, Inc. announced that it has received ¥800 million in funding from JAFCO Group Co., Ltd., STRIVE, Inc., SBI Investment Co., Ltd., Japan Post Capital Co., Ltd., GMO Venture Partners, Inc., Nippon Chemiphar Co., Ltd.	16/08/21	CI
MOLCURE, Inc. announced that it has received ¥100 million in funding from The Dai-Ichi Life Insurance Company, Limited, Nippon Chemiphar Co., Ltd.	26/11/18	CI
MOLCURE, Inc. announced that it has received funding from GMO Venture Partners, Inc., Nippon Chemiphar Co., Ltd.	30/03/18	CI
Tranche Update on Nippon Chemiphar Co., Ltd.'s Equity Buyback Plan announced on January 31, 2018.	01/02/18	CI
Nippon Chemiphar Co., Ltd.'s Equity Buyback announced on January 31, 2018 has expired with 25,000 shares for ¥117.75 million.	31/01/18	CI
Nippon Chemiphar Co., Ltd. announces an Equity Buyback for 30,000 shares, representing 0.82% for ¥141.3 million.	31/01/18	CI
Nippon Chemiphar Co., Ltd. authorizes a Buyback Plan.	30/01/18	CI
Nippon Chemiphar Co., Ltd. Announces the Phase-I Clinical Trial of NC-2500, a Novel Xanthine Oxidoreductase Inhibitor	29/11/17	CI
Nippon Chemiphar Co., Ltd.(TSE:4539) dropped from S&P Global BMI Index	18/09/17	CI
Tranche Update on Nippon Chemiphar Co., Ltd.'s Equity Buyback Plan announced on August 1, 2017.	02/08/17	CI
Nippon Chemiphar Co., Ltd.'s Equity Buyback announced on August 1, 2017 has expired with 192,600 shares, representing 5.05% for ¥999.59 million.	01/08/17	CI
Nippon Chemiphar Co., Ltd. announces an Equity Buyback for 200,000 shares, representing 5.19% for ¥1,038 million.	01/08/17	CI
Nippon Chemiphar Co., Ltd. authorizes a Buyback Plan.	31/07/17	CI
Nippon Chemiphar Co., Ltd. Announces Earnings Results for the First Quarter Ended June 30, 2017; Provides Earnings Guidance for the Second Quarter and Full Year 2017	30/07/17	CI
Tranche Update on Nippon Chemiphar Co., Ltd.'s Equity Buyback Plan announced on October 31, 2016.	04/04/17	CI
Nippon Chemiphar Co., Ltd's Equity Buyback announced on October 31, 2016 has expired with the repurchase of 94,800 shares for ¥486.76 million.	30/03/17	CI
Nippon Chemiphar Co., Ltd. Reports Earnings Results for the Third Quarter Ended December 31, 2016; Revises Earnings Guidance for the Full Year Ending March 31, 2017	30/01/17	CI
Tranche Update on Nippon Chemiphar Co., Ltd.'s Equity Buyback Plan announced on October 31, 2016.	05/01/17	CI

Chart Nippon Chemiphar Co., Ltd.

Duration

Period

More charts

NIPPON CHEMIPHAR CO., LTD. is a Japan-based company centered on ethical pharmaceutical products and mainly engaged in the pharmaceutical, health and beauty related businesses. The Companyâs Pharmaceutical segment is engaged in the manufacture and sale of ethical pharmaceutical products. Other businesses include entrusted safety testing, healthcare and real estate leasing business. The Company mainly operates in Japan and Vietnam.

Sector

Pharmaceuticals

Calendar

30/07/2024 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
NIPPON CHEMIPHAR CO., LTD.	+0.32%	36.93M
ELI LILLY AND COMPANY	+32.09%	694B
NOVO NORDISK A/S	+29.39%	593B
JOHNSON & JOHNSON	-1.34%	371B
MERCK & CO., INC.	+20.34%	331B
ABBVIE INC.	+7.39%	290B
ASTRAZENECA PLC	+14.25%	239B
ROCHE HOLDING AG	-3.03%	209B
NOVARTIS AG	+10.02%	209B
AMGEN INC.	+8.49%	169B

Other Pharmaceuticals